OBJECTIVES: We aimed to report the long-term outcomes of osteoid osteoma patients and to determine CT and dynamic contrast-enhanced MR imaging characteristics of radiofrequency ablation (RFA) treatment related changes of osteoid osteoma between follow-up periods. MATERIALS AND METHODS: Thirty patients (seven female, 23 male) who underwent CT-guided RFA of osteoid osteoma were included. Follow-up imaging examinations were divided into two subgroups; first (1-3 months) and second (> 6 months) periods. Nidus size, calcification, cortical thickening, maximum signal intensity (SImax), time of SImax (Tmax), slope of signal intensity-time (SIT) curves were noted. CT and dynamic MR imaging findings were compared between follow-up periods. RESULTS: Clinical success rate was 100%. The mean of OO nidi size was 5.85 ± 1.98 mm before treatment. There was a significant difference for OO nidi sizes between pretreatment and second follow-up period examinations (p = 0.002). SImax and slope of SIT curves of all patients (100%) showed decrease on follow-up MRIs. There was a significant decrease for SImax values between pretreatment and second follow-up period. There was a significant decrease for slope of SIT curves between pretreatment and both follow-up periods. CONCLUSIONS: RFA is an effective and safe treatment choice for osteoid osteomas. On follow-up imaging, slope of SIT curve and Tmax have the most important positive predictive value for long-term outcomes and single dynamic contrast-enhanced MRI within first 3 months after treatment may be sufficient for symptom-free patients.
OBJECTIVES: We aimed to report the long-term outcomes of osteoid osteomapatients and to determine CT and dynamic contrast-enhanced MR imaging characteristics of radiofrequency ablation (RFA) treatment related changes of osteoid osteoma between follow-up periods. MATERIALS AND METHODS: Thirty patients (seven female, 23 male) who underwent CT-guided RFA of osteoid osteoma were included. Follow-up imaging examinations were divided into two subgroups; first (1-3 months) and second (> 6 months) periods. Nidus size, calcification, cortical thickening, maximum signal intensity (SImax), time of SImax (Tmax), slope of signal intensity-time (SIT) curves were noted. CT and dynamic MR imaging findings were compared between follow-up periods. RESULTS: Clinical success rate was 100%. The mean of OO nidi size was 5.85 ± 1.98 mm before treatment. There was a significant difference for OO nidi sizes between pretreatment and second follow-up period examinations (p = 0.002). SImax and slope of SIT curves of all patients (100%) showed decrease on follow-up MRIs. There was a significant decrease for SImax values between pretreatment and second follow-up period. There was a significant decrease for slope of SIT curves between pretreatment and both follow-up periods. CONCLUSIONS: RFA is an effective and safe treatment choice for osteoid osteomas. On follow-up imaging, slope of SIT curve and Tmax have the most important positive predictive value for long-term outcomes and single dynamic contrast-enhanced MRI within first 3 months after treatment may be sufficient for symptom-free patients.
Authors: Clinton H Pinto; Anthonie H M Taminiau; Geert M Vanderschueren; Pancras C W Hogendoorn; Johan L Bloem; Willem R Obermann Journal: AJR Am J Roentgenol Date: 2002-12 Impact factor: 3.959
Authors: Louis Lassalle; R Campagna; G Corcos; A Babinet; F Larousserie; J Stephanazzi; A Feydy Journal: Skeletal Radiol Date: 2017-04-20 Impact factor: 2.199
Authors: Ralf-Thorsten Hoffmann; Tobias F Jakobs; Constanze H Kubisch; Christoph G Trumm; Christof Weber; Hans-Roland Duerr; Thomas K Helmberger; Maximilian F Reiser Journal: Eur J Radiol Date: 2009-01-13 Impact factor: 3.528
Authors: Geert M Vanderschueren; Antoni H M Taminiau; Wim R Obermann; Annette A van den Berg-Huysmans; Johan L Bloem; Arian R van Erkel Journal: Skeletal Radiol Date: 2007-05-11 Impact factor: 2.199
Authors: Andreas H Mahnken; Philipp Bruners; Heide Delbrück; Rolf W Günther; Cedric Plumhans Journal: J Med Imaging Radiat Oncol Date: 2012-09-05 Impact factor: 1.735
Authors: Majid Maybody; Mohamed M Soliman; Sinchun Hwang; Adrian Gonzalez-Aguirre; Ernesto G Santos Martin; Elena Kaye; Meier Hsu; Chaya Moskowitz; John H Healey; Nicola Fabbri Journal: SN Compr Clin Med Date: 2020-09-14